Early expression of herpes simplex virus (HSV) proteins and reactivation of latent infection

. 2000 ; 45 (1) : 7-28.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid11200675

During the last decade, new data accumulated describing the early events during herpes simplex virus 1 (HSV-1) replication occurring before capsid formation and virion envelopment. The HSV virion carries its own specific transcription initiation factor (alpha-TIF), which functions together with other components of the cellular transcriptase complex to mediate virus-specific immediate early (IE) transcription. The virus-coded IE proteins are the transactivator and regulatory elements modulating early transcription and subsequent translation of nonstructural virus-coded proteins needed mainly for viral DNA synthesis and for the supply of corresponding nucleoside components. They also cooperate at the late transcription and translation of the virion (capsid, tegument and envelope) proteins. In addition, the transactivator IE proteins down-regulate their own transcription, while others facilitate viral mRNA processing or interfere with the presentation of newly synthesized virus antigens. Establishment of latency is closely related to the transcription of a separate category of transcripts, termed latency-associated (LAT). Formation of LATs occurs mainly in nondividing neurons which are metabolically less active and express lower levels of cellular transcription factors (nonpermissive cells). Expression of the stable non-spliced (2 kb), and especially of stable spliced (1.5 and 1.45 kb) LATs is a prerequisite for HSV reactivation. Different HSV genomes (from various HSV strains) do not undergo IE transcription at the same rate. Restricted IE transcription and the absence of viral DNA synthesis favors LAT formation and persistence of the silenced genome. Uneven levels of LAT expression and differences in the metabolic state of carrier neurons influence the reactivation competence. Under artificial or natural activation conditions, sufficient amounts of IE transactivator proteins and proteins promoting nucleoside metabolism are synthesized even in the absence of the viral alpha-TIF facilitating reactivation.

Zobrazit více v PubMed

J Virol. 1987 Dec;61(12):3820-6 PubMed

J Virol. 1998 Aug;72(8):6888-92 PubMed

Cell. 1982 Dec;31(2 Pt 1):355-65 PubMed

Mol Cell Biol. 1997 Oct;17(10):6139-46 PubMed

J Gen Virol. 1998 Jan;79 ( Pt 1):117-24 PubMed

J Virol. 1999 May;73(5):3810-7 PubMed

J Virol. 1996 Aug;70(8):5255-65 PubMed

Nucleic Acids Res. 1990 Dec 11;18(23):6871-80 PubMed

J Virol. 1998 Feb;72(2):1177-85 PubMed

Lancet. 1976 Feb 21;1(7956):397-9 PubMed

J Virol. 1997 Aug;71(8):5885-93 PubMed

Acta Virol. 1998 Apr;42(2):103-18 PubMed

J Virol. 1994 Dec;68(12):8045-55 PubMed

Annu Rev Biochem. 1997;66:347-84 PubMed

J Virol. 1997 Sep;71(9):6850-62 PubMed

J Virol. 1998 Apr;72(4):3495-500 PubMed

Proc Natl Acad Sci U S A. 1981 Oct;78(10):6276-80 PubMed

Virus Genes. 1999;18(1):81-90 PubMed

EMBO J. 1989 Feb;8(2):505-11 PubMed

J Virol. 1997 Feb;71(2):1019-24 PubMed

J Virol. 1997 Mar;71(3):1757-65 PubMed

Prog Med Virol. 1992;39:76-115 PubMed

Biochem J. 1992 Jun 15;284 ( Pt 3):667-73 PubMed

J Virol. 1999 Nov;73(11):9456-67 PubMed

Nucleic Acids Res. 1996 Jun 15;24(12):2324-30 PubMed

Arch Virol. 1990;113(1-2):107-13 PubMed

Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9056-60 PubMed

J Virol. 1999 Dec;73(12):9726-33 PubMed

J Virol. 1994 Nov;68(11):6871-82 PubMed

J Gen Virol. 1988 Jul;69 ( Pt 7):1531-74 PubMed

J Virol. 1998 Jul;72(7):5343-50 PubMed

J Virol. 1994 Apr;68(4):2239-52 PubMed

J Virol. 1995 Mar;69(3):1389-99 PubMed

J Virol. 1993 Dec;67(12):7201-14 PubMed

J Gen Virol. 1994 Oct;75 ( Pt 10):2691-8 PubMed

J Virol. 1982 Dec;44(3):939-49 PubMed

Mol Cell Biol. 1996 Aug;16(8):4404-13 PubMed

J Virol. 1999 May;73(5):4305-15 PubMed

J Virol. 1988 Nov;62(11):4307-20 PubMed

J Virol. 1994 Mar;68(3):1283-92 PubMed

J Virol. 1996 Mar;70(3):1931-40 PubMed

J Virol. 1992 May;66(5):2916-27 PubMed

Mol Cells. 1999 Jun 30;9(3):277-80 PubMed

J Virol. 1988 May;62(5):1832-5 PubMed

J Virol. 1999 Mar;73(3):2161-72 PubMed

Virology. 1993 Feb;192(2):687-91 PubMed

J Virol. 1991 Dec;65(12):6800-10 PubMed

EMBO J. 1996 Jul 1;15(13):3247-55 PubMed

Acta Virol. 1983 Sep;27(5):442-50 PubMed

J Gen Virol. 1992 May;73 ( Pt 5):1287-91 PubMed

J Virol. 1992 Apr;66(4):2157-69 PubMed

Cell. 1991 Feb 8;64(3):475-8 PubMed

J Virol. 1996 Aug;70(8):5384-94 PubMed

J Virol. 1996 Feb;70(2):976-84 PubMed

Nature. 1988 Oct 6;335(6190):563-4 PubMed

Arch Virol. 1994;137(3-4):209-28 PubMed

J Virol. 1993 Nov;67(11):6903-8 PubMed

Virology. 1992 Nov;191(1):1-8 PubMed

Nucleic Acids Res. 1986 Jan 24;14(2):929-43 PubMed

J Virol. 1996 Mar;70(3):2014-8 PubMed

J Virol. 1999 Jan;73(1):417-26 PubMed

J Virol. 1997 Feb;71(2):1547-57 PubMed

J Gen Virol. 1995 Feb;76 ( Pt 2):321-32 PubMed

Virus Genes. 1997;15(2):155-9 PubMed

J Virol. 1987 Apr;61(4):992-1001 PubMed

J Virol. 1986 Feb;57(2):446-55 PubMed

J Virol. 1997 Aug;71(8):5878-84 PubMed

Curr Eye Res. 1986 Mar;5(3):241-6 PubMed

Invest Ophthalmol Vis Sci. 1998 Sep;39(10):1847-53 PubMed

J Gen Virol. 1987 Jun;68 ( Pt 6):1761-5 PubMed

J Virol. 1997 Oct;71(10):7328-36 PubMed

J Gen Virol. 1998 Sep;79 ( Pt 9):2093-8 PubMed

Arch Virol. 1987;97(1-2):137-44 PubMed

Nucleic Acids Res. 1984 Feb 24;12(4):2061-79 PubMed

J Virol. 1996 Aug;70(8):5476-86 PubMed

J Virol. 1989 Jun;63(6):2861-5 PubMed

J Virol. 1990 Jul;64(7):3269-79 PubMed

J Gen Virol. 1994 Mar;75 ( Pt 3):647-50 PubMed

J Virol. 1991 Aug;65(8):4142-52 PubMed

J Virol. 1997 Sep;71(9):6777-85 PubMed

J Virol. 1998 Sep;72(9):7115-24 PubMed

Acta Virol. 1975 Jan;19(1):19-28 PubMed

Proc Natl Acad Sci U S A. 1980 Dec;77(12):7122-6 PubMed

J Neurovirol. 1996 Aug;2(4):268-78 PubMed

J Virol. 1997 Dec;71(12):9188-97 PubMed

J Virol. 1988 May;62(5):1479-85 PubMed

J Virol. 1998 Nov;72(11):8525-31 PubMed

J Virol. 1997 Jul;71(7):5423-31 PubMed

Virus Genes. 1998;16(3):239-51 PubMed

Mol Cell Biol. 1995 Jul;15(7):3618-26 PubMed

J Virol. 1997 Jul;71(7):5268-76 PubMed

J Virol. 1996 May;70(5):2883-93 PubMed

J Gen Virol. 1990 Apr;71 ( Pt 4):953-7 PubMed

J Virol. 1989 Feb;63(2):943-7 PubMed

J Virol. 1996 May;70(5):3137-41 PubMed

Nature. 1986 Aug 14-20;322(6080):656-9 PubMed

J Virol. 1999 Apr;73(4):3246-57 PubMed

J Virol. 1998 Oct;72(10):7785-95 PubMed

Nature. 1995 Jun 1;375(6530):415-8 PubMed

Nat New Biol. 1972 Feb 16;235(59):216-7 PubMed

J Virol. 1991 May;65(5):2724-7 PubMed

J Virol. 1997 Jun;71(6):4614-25 PubMed

J Virol. 1998 Aug;72(8):6752-7 PubMed

Intervirology. 1991;32(2):76-92 PubMed

Genes Dev. 1991 Dec;5(12B):2555-66 PubMed

J Virol. 1999 Apr;73(4):3418-23 PubMed

J Virol. 1998 Jul;72(7):5626-37 PubMed

J Virol. 1988 Dec;62(12):4577-85 PubMed

Neuron. 1990 Feb;4(2):215-22 PubMed

J Virol. 1989 Sep;63(9):3844-51 PubMed

J Gen Virol. 1988 May;69 ( Pt 5):1079-83 PubMed

Virology. 1993 Aug;195(2):337-47 PubMed

J Virol. 1997 Oct;71(10):7807-13 PubMed

Mol Cell Biol. 1996 Jun;16(6):3085-93 PubMed

Cell. 1996 Nov 1;87(3):427-36 PubMed

J Virol. 1998 Aug;72(8):6581-91 PubMed

Bacteriol Rev. 1964 Dec;28:472-9 PubMed

J Virol. 1997 Sep;71(9):6714-9 PubMed

Virology. 1992 Jul;189(1):150-60 PubMed

J Virol. 1997 Nov;71(11):8602-14 PubMed

Annu Rev Biochem. 1992;61:419-40 PubMed

J Gen Virol. 1975 Sep;28(3):341-53 PubMed

J Virol. 1999 Aug;73(8):6618-25 PubMed

J Virol. 1999 Jul;73(7):5593-604 PubMed

J Virol. 1996 Sep;70(9):5962-7 PubMed

J Neurovirol. 1997 Jun;3(3):212-24 PubMed

J Virol. 1995 Nov;69(11):7187-95 PubMed

J Virol. 1996 Jan;70(1):282-91 PubMed

J Gen Virol. 1999 May;80 ( Pt 5):1271-1282 PubMed

Science. 1990 Nov 30;250(4985):1262-6 PubMed

Intervirology. 1991;32(2):101-15 PubMed

J Virol. 1996 Mar;70(3):1969-80 PubMed

Folia Microbiol (Praha). 1999;44(5):467-86 PubMed

J Virol. 1997 Aug;71(8):6083-93 PubMed

J Gen Virol. 1988 Jun;69 ( Pt 6):1147-56 PubMed

Virology. 1998 Jun 20;246(1):145-57 PubMed

Virology. 1999 May 10;257(2):341-51 PubMed

J Virol. 1995 Nov;69(11):7087-98 PubMed

J Virol. 1990 Jul;64(7):3417-26 PubMed

J Biol Chem. 1995 Sep 8;270(36):21312-8 PubMed

J Virol. 1994 Feb;68(2):823-33 PubMed

Virus Res. 1997 Jul;50(1):95-106 PubMed

Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10379-84 PubMed

Folia Microbiol (Praha). 1999;44(6):713-9 PubMed

J Virol. 1993 Oct;67(10):6125-35 PubMed

J Virol. 1999 Jan;73(1):650-7 PubMed

Proc Natl Acad Sci U S A. 1988 Sep;85(17):6347-51 PubMed

J Virol. 1998 Jun;72(6):5067-75 PubMed

Microb Pathog. 1989 Aug;7(2):121-34 PubMed

Invest Ophthalmol Vis Sci. 1981 Sep;21(3):442-9 PubMed

J Virol. 1998 Jul;72(7):5373-82 PubMed

Nature. 1983 Apr 7;302(5908):523-5 PubMed

J Virol. 1990 Jul;64(7):3471-85 PubMed

J Gen Virol. 2000 Jan;81(Pt 1):1-19 PubMed

J Virol. 1994 Mar;68(3):1271-82 PubMed

Virology. 1995 Feb 20;207(1):107-16 PubMed

J Virol. 1990 Apr;64(4):1704-15 PubMed

J Virol. 1997 Sep;71(9):7039-47 PubMed

Nature. 1995 Jun 1;375(6530):411-5 PubMed

J Virol. 1992 May;66(5):2904-15 PubMed

J Virol. 1990 Nov;64(11):5396-402 PubMed

J Virol. 1992 Jan;66(1):341-8 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...